Oct 2026· International Journal of COPD· Vol 21· 0 citations· 39 references
Medicine
TL;DR
Higher baseline neutrophil-to-lymphocyte ratio was associated with modestly faster lung function decline after adjustment for disease severity, but the association depended on the adjustment model and does not establish causality or individual predictive value.
Abstract
Background Systemic inflammation may contribute to heterogeneous lung function trajectories in chronic obstructive pulmonary disease (COPD), but evidence linking the neutrophil-to-lymphocyte ratio (NLR) to longitudinal forced expiratory volume in one second (FEV1) change is limited. Methods We analyzed repeated spirometry from a single-center retrospective cohort. Eligibility required clinically stable chronic obstructive pulmonary disease, baseline blood counts, at least two qualified spirometry assessments, and at least 12 months of recorded follow-up. Linear mixed-effects models estimated the association between baseline log2-transformed neutrophil-to-lymphocyte ratio and annual forced expiratory volume in one second (FEV1) change. Sequential models added demographic and exposure variables, then baseline disease severity. Post hoc analyses examined common visit windows and sensitivity to covariate selection. Results Of 819 patients, 667 met longitudinal cohort criteria; 640 patients with 2525 qualified observations entered the complete-case model. Median recorded follow-up was 22 months, with a median of four qualified assessments per patient. Additional FEV1 decline per ratio doubling increased from 4.05 mL/year unadjusted (95% confidence interval −1.95 to 10.04) to 8.26 mL/year after severity adjustment (2.29 to 14.23; P=0.0068). Comparisons within the same 640 patients also showed model dependence. Restriction to baseline, 6-month and 12-month visit windows yielded 12.78 mL/year (2.72 to 22.84; 269 patients). The corresponding baseline, 12-month and 24-month estimate was imprecise (13.57 mL/year; −0.04 to 27.17; 116 patients). Conclusion Higher baseline neutrophil-to-lymphocyte ratio was associated with modestly faster lung function decline after adjustment for disease severity. The association depended on the adjustment model and does not establish causality or individual predictive value. Prospective studies with standardized follow-up are needed.
Background Preserved ratio impaired spirometry (PRISm), defined as a post-bronchodilator forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) ratio ≥0.70 with a post-bronchodilator FEV1 <80% predicted, is a heterogeneous spirometric pattern associated with adverse clinical outcomes and progression...
Ruo-Bing Zhao, Ying-Xiang Lin· International Journal of COP...· 0 citations
Background Asthma–chronic obstructive pulmonary disease overlap (ACO) is associated with persistent airflow limitation and adverse clinical outcomes. Whether the neutrophil-to-lymphocyte ratio (NLR) and derived NLR (dNLR) show nonlinear associations with ACO prevalence among patients with asthma is uncertain. Methods W...
Ru-Yue Jin, Shu-Ni Wang, Jia-Jun Zhang et al.· Frontiers in Medicine· 0 citations
Chronic obstructive pulmonary disease (COPD) is a significant public health issue and ranks among the leading causes of morbidity and mortality globally.
This work aimed to examine the relationship between the neutrophil-to-lymphocyte ratio (NLR) and the clinical and functional outcomes of COPD, as well as t...
Tasneem M. M. Abdelfatah, H. Salem, A. S. Elbendary et al.· Egyptian Journal of Chest Di...· 0 citations
One-year progression of CT emphysema subtypes predicted accelerated FEV₁ decline, supporting their potential use as intermediate endpoints in COPD trials and evaluating associations between one-year QCT measure changes and FEV₁ decline from visits two through five.
Emilia A. Hermann, E. Hoffman, Elsa D. Angelini et al.· American Journal of Respirat...· 0 citations
BACKGROUND
The clinical phenotypes, prognosis, and heterogeneity of mild-to-moderate chronic obstructive pulmonary disease (COPD) have not been systematically evaluated.
RESEARCH QUESTION
Do different clinical phenotypes of mild-to-moderate COPD have different prognoses?
STUDY DESIGN AND METHODS
We analysed the bas...
Fan Wu, Q. Wan, K. Zhou et al.· Chest· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.